BrainInsight

BrainInsight™ is an automated software tool that processes low-field (0.064 T) MR images to provide quantitative measurements of brain structures. It employs machine learning algorithms for tasks such as segmentation of the whole brain and lateral ventricles, and calculation of midline shift, delivering reports and annotated images for clinical review.

BrainInsight™ is a fully automated medical software designed for the post-processing of Magnetic Resonance (MR) images, specifically to aid clinicians in assessing low-field (0.064 T) structural MRIs. Its primary function is to provide automatic labeling, spatial measurement, and volumetric quantification of various brain structures. The system operates using a proprietary internal pipeline based on machine learning tools, which processes 3D MRI series including T1 Gray/White, T2-weighted, T2-Fast, and FLAIR images. BrainInsight delivers its output as annotated and segmented images in standard formats, complete with color overlays and detailed reports, which can be viewed on third-party workstations and Picture Archive and Communications Systems (PACS). The software is indicated for several applications depending on patient age and image type: midline shift and lateral ventricle analysis for patients aged 2 and older (using T1, T2, T2-Fast, FLAIR sequences), and whole brain segmentation for adults aged 18 and older (using T1 and T2 sequences). Performance evaluations demonstrated the software's accuracy, with midline shift measurements showing mean absolute errors between 0.75 mm and 1.01 mm depending on the MRI sequence. For volumetric segmentation, Dice coefficients for lateral ventricles ranged from 82% to 89% and for whole brain from 95% to 96% when compared to annotator consensus, indicating high accuracy in its quantitative outputs for clinical support.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does BrainInsight's performance with 0.064 T MRI data compare to software analyzing images from higher field strength MRIs, particularly for detecting subtle pathologies?; What are the specific machine learning models and architectures used in BrainInsight's proprietary pipeline, and how do they address potential challenges of low-field image quality?; What is the clinical significance of the reported discrepancies between BrainInsight's measurements (e.g., Dice coefficients, midline shift error) and expert annotators, especially in borderline cases?; How robust is the software to variations in image acquisition parameters or common artifacts encountered in low-field MRI, beyond the specified protocols?; Are there plans to expand BrainInsight's capabilities to include other brain structures, pathologies, or quantitative metrics relevant to low-field MRI analysis?